Traditional medicine Bazi Bushen potentiates immunosurveillance of senescent liver cancer cells via cGAS-STING signaling activation in macrophages
- Cancer Lett. 2025 Feb 8:217544. doi: 10.1016/j.canlet.2025.217544.
- 1. Department of Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China.
- 2. Department of Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China; National Center for Liver Cancer, Naval Medical University, Shanghai 201805, China; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute/Hospital, Naval Medical University, Shanghai 200438, China; Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Shanghai 200438, China; Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education, Shanghai 200438, China.
- 3. National Center for Liver Cancer, Naval Medical University, Shanghai 201805, China; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute/Hospital, Naval Medical University, Shanghai 200438, China.
- 4. Department of Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China. Electronic address: [email protected].
- 5. Department of Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China; National Center for Liver Cancer, Naval Medical University, Shanghai 201805, China; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute/Hospital, Naval Medical University, Shanghai 200438, China; Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Shanghai 200438, China; Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education, Shanghai 200438, China. Electronic address: [email protected].
- 6. Department of Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China; National Center for Liver Cancer, Naval Medical University, Shanghai 201805, China; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute/Hospital, Naval Medical University, Shanghai 200438, China; Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Shanghai 200438, China; Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education, Shanghai 200438, China. Electronic address: [email protected].
Senescent Cancer cells often evade immune clearance to exert profound effects on Cancer progression and therapy resistance. Improving immunosurveillance to eliminate senescent Cancer cells is a crucial measure to enhance anti-cancer therapy. Bazi Bushen (BZBS) is a traditional medicine with the function of relieving fatigue and delaying ageing, but its role in tumor treatment remains poorly understood. Herein, we find that BZBS promotes immunosurveillance of both chemotherapy- and oncogene-induced senescent liver Cancer cells, further leading to enhanced chemotherapy efficacy and dramatic tumor repression in mice. Mechanistically, BZBS induces mitochondrial DNA leakage by mitochondrial damage to further activate cGAS-STING signaling in macrophages. Subsequently, cGAS-STING signaling activation in macrophages recruits CD8+ T cells into tumor and promotes the anti-tumor activity of CD8+ T cells to eradicate senescent Cancer cells. Furthermore, host STING is responsible for BZBS-mediated immunosurveillance of senescent liver Cancer cells in mice. Therefore, our findings unveil the role of traditional medicine BZBS in activating cGAS-STING signaling and potentiating senescence immunosurveillance to enhance anti-cancer therapy.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
-
99.79%, Biochemical Assay ReagentResearch Areas: Others